Buscar
01/07/2022
Small renal masses in kidney transplantation: Overview of clinical impact and management in donors and recipients
Piana, A, Andras, I, Diana, P, Verri, P, Galliol, A, Campi, R, Prudhomme, T, Hevia, V, Boissier, R, Breda, A, Territo, A. Small renal masses in kidney transplantation: Overview of clinical impact and management in donors and recipients. Asian Journal Of Urology. 2022; 9(3)DOI:10.1016/j.ajur.2022.06.001. PMID:36035353. IF:(Q/D).
01/07/2022
Computerized tomography scan evaluation after fresh osteochondral allograft transplantation of the knee correlates with clinical outcomes
Gelber, PE, Ramirez-Bermejo, E, Grau-Blanes, A, Gonzalez-Osuna, A, Farinas, O. Computerized tomography scan evaluation after fresh osteochondral allograft transplantation of the knee correlates with clinical outcomes. INTERNATIONAL ORTHOPAEDICS. 2022; 46(7)DOI:10.1007/s00264-022-05373-6. PMID:35411436. IF:2.700(Q2/4D).
01/07/2022
Nuclear receptor NOR-1 (Neuron-derived Orphan Receptor-1) in pathological vascular remodelling and vascular remodelling
Ballester-Servera, C, Canes, L, Alonso, J, Puertas, L, Tauron, M, Rodriguez, C, Martinez-Gonzalez, J. Nuclear receptor NOR-1 (Neuron-derived Orphan Receptor-1) in pathological vascular remodelling and vascular remodelling. Clinica E Investigacion En Arteriosclerosis. 2022; 34(4)DOI:10.1016/j.arteri.2022.03.002. PMID:35581107. IF:(Q/D).
01/07/2022
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure
Marroquin L., Tirado-Conte G., Pracon R., Streb W., Gutierrez H., Boccuzzi G., Arzamendi-Aizpurua D., Cruz-González I., Ruiz-Nodar J.M., Kim, JS, Freixa X., Lopez-Minguez J.R., De Backer O., Ruiz-Salmeron R., Dominguez A., McInerney A., Peral V., Estevez-Loureiro R., Fernandez-Nofrerias E., Freitas-Ferraz A.B., Saia F., Huczek Z., Gheorghe L., Salinas P., Demkow M., Delgado-Arana J.R., Peregrina, EF, Kalarus Z., Laffond, AE, Jang Y., Camacho, JCF, Lee, OH, Hernández-Garcia J.M., Mas-Llado C., Queija, BC, Amat-Santos I.J., Dabrowski M., Rodés-Cabau J., Franco, LN. Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure. HEART. 2022; 108(14)DOI:10.1136/heartjnl-2021-319811. PMID:34686564. IF:5.700(Q2/3D).
01/07/2022
Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study
Rodríguez-Mañero M., Baluja A., Hernández J., Muñoz C., Calvo D., Fernández-Armenta J., García-Fernández A., Zorio E., Arce-León Á., Sánchez-Gómez J.M., Mosquera-Pérez I., Arias M.Á., Díaz-Infante E., Expósito V., Jiménez-Ramos V., Teijeira E., Cañadas-Godoy M.V., Guerra-Ramos J.M., Oloriz T., Basterra N., Sousa P., Elices-Teja J., García-Bolao I., González-Juanatey J.R., Brugada R., Gimeno J.R., Brugada J., Arbelo E.. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 75(7)DOI:10.1016/j.recesp.2021.07.006. PMID:. IF:(Q/D).
01/07/2022
Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey (Apr, 10.1093/europace/euac011, 2022)
Farkowski, MM, Guerra, JM, Marijon, E, Boveda, S. Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey (Apr, 10.1093/europace/euac011, 2022). EUROPACE. 2022; 24(7)DOI:10.1093/europace/euac051. PMID:. IF:6.100(Q1/3D).
01/07/2022
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Gorog, DA, Storey, RF, Gurbel, PA, Tantry, US, Berger, JS, Chan, MY, Duerschmied, D, Smyth, SS, Parker, WAE, Ajjan, RA, Vilahur, G, Badimon, L, ten Berg, JM, ten Cate, H, Peyvandi, F, Wang, TT, Becker, RC. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nature Reviews Cardiology. 2022; 19(7)DOI:10.1038/s41569-021-00665-7. PMID:35027697. IF:49.600(Q1/1D).
01/07/2022
Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling
Gharanei M., Shafaattalab S., Sangha S., Gunawan M., Laksman Z., Hove-Madsen L., Tibbits G.F.. Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling. METHODS. 2022; 203DOI:10.1016/j.ymeth.2021.06.009. PMID:34144175. IF:4.800(Q1/2D).
01/07/2022
Investigating inherited arrhythmias using hiPSC-derived cardiomyocytes
Arslanova A., Shafaattalab S., Lin E., Barszczewski T., Hove-Madsen L., Tibbits G.F.. Investigating inherited arrhythmias using hiPSC-derived cardiomyocytes. METHODS. 2022; 203DOI:10.1016/j.ymeth.2021.06.015. PMID:34197925. IF:4.800(Q1/2D).
01/07/2022
Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis
Lobato-Delgado, B, Priego-Torres, B, Sanchez-Morillo, D. Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis. Cancers. 2022; 14(13)DOI:10.3390/cancers14133215. PMID:35804988. IF:5.200(Q2/3D).
01/07/2022
Type 1 diabetes and pregnancy: An update on glucose monitoring and insulin treatment
Amigo, J, Corcoy, R. Type 1 diabetes and pregnancy: An update on glucose monitoring and insulin treatment. Endocrinologia Diabetes y Nutricion. 2022; 69(6)DOI:10.1016/j.endien.2022.06.008. PMID:35787359. IF:1.900(Q4/9D).
01/07/2022
Attachment-Based Compassion Therapy for Reducing Anxiety and Depression in Fibromyalgia
Santos, A, Crespo, I, Perez-Aranda, A, Beltran-Ruiz, M, Puebla-Guedea, M, Garcia-Campayo, J. Attachment-Based Compassion Therapy for Reducing Anxiety and Depression in Fibromyalgia. International Journal of Environmental Research and Public Health. 2022; 19(13)DOI:10.3390/ijerph19138152. PMID:35805810. IF:4.614(Q1/3D).
01/07/2022
Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases
Baiges A., Cerda E., Amicone C., Téllez L., Alvarado-Tapias E., Puente A., Fortea J.I., Llop E., Rocha F., Orts L., Ros-Fargas O., Vizcarra P., Zekrini K., Lounes O.A., Touati G., Jiménez-Esquivel N., Serrano M.J., Falgà A., Magaz M., Olivas P., Betancourt F., Perez-Campuzano V., Turon F., Payancé A., Goria O., Rautou P.-E., Hernández-Gea V., Villanueva C., Albillos A., Plessier A., García-Pagán J.-C.. Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases. Clinical Gastroenterology and Hepatology. 2022; 20(7)DOI:10.1016/j.cgh.2021.12.032. PMID:34968728. IF:12.600(Q1/1D).
01/07/2022
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU
Riestra, S, Taxonera, C, Zabana, Y, Carpio, D, Chaparro, M, Barrio, J, Rivero, M, Lopez-Sanroman, A, Esteve, M, de Francisco, R, Bastida, G, Garcia-Lopez, S, Manosa, M, Martin-Arranz, MD, Perez-Calle, JL, Guardiola, J, Munoz, F, Arranz, L, Cabriada, JL, Garcia-Sepulcre, MF, Navarro, M, Montoro-Huguet, MA, Ricart, E, Bermejo, F, Calvet, X, Piqueras, M, Garcia-Planella, E, Marquez, L, Minguez, M, Van Domselar, M, Bujanda, L, Aldeguer, X, Sicilia, B, Iglesias, E, Alcain, G, Perez-Martinez, I, Rolle, V, Castano-Garcia, A, Gisbert, JP, Domenech, E. Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU. Journal of Clinical Medicine. 2022; 11(13)DOI:10.3390/jcm11133915. PMID:35807201. IF:3.900(Q2/4D).
01/07/2022
Tegumentary leishmaniasis by Leishmania braziliensis complex in Cochabamba, Bolivia including the presence of L. braziliensis outlier Tegumentary leishmaniasis in Cochabamba, Bolivia
Torrico, MC, Fernandez-Arevalo, A, Ballart, C, Solano, M, Rojas, E, Ariza, E, Tebar, S, Lozano, D, Abras, A, Gascon, J, Picado, A, Munoz, C, Torrico, F, Gallego, M. Tegumentary leishmaniasis by Leishmania braziliensis complex in Cochabamba, Bolivia including the presence of L. braziliensis outlier Tegumentary leishmaniasis in Cochabamba, Bolivia. Transboundary and Emerging Diseases. 2022; 69(4)DOI:10.1111/tbed.14228. PMID:34232559. IF:4.300(Q1/1D).
01/07/2022
Clinical usefulness of quantifying microbial load from diabetic foot ulcers: A multicenter cohort study
Soldevila-Boixader, L, Mur, I, Morata, L, Sierra, Y, Rivera, A, Bosch, J, Montero-Saez, A, Fernandez-Reinales, AJ, Marti, S, Benito, N, Murillo, O. Clinical usefulness of quantifying microbial load from diabetic foot ulcers: A multicenter cohort study. DIABETES RESEARCH AND CLINICAL PRACTICE. 2022; 189DOI:10.1016/j.diabres.2022.109975. PMID:35777672. IF:5.100(Q2/3D).
01/07/2022
Bronchiectasis exacerbations: certainties and future challenges
de la Rosa-Carrillo, D, GARCIA-CLEMENTE, MM. Bronchiectasis exacerbations: certainties and future challenges. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2022; 26(7)DOI:10.5588/ijtld.22.0185. PMID:35768930. IF:4.000(Q2/5D).
01/07/2022
Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis
Clemente, MG, Olveira, C, Giron, R, Maiz, L, Sibila, O, Golpe, R, Menendez, R, Rodriguez, J, Barreiro, E, Hermosa, JLR, Prados, C, de la Rosa, D, Carbajal, CM, Solis, M, Martinez-Garcia, MA. Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis. Journal of Clinical Medicine. 2022; 11(14)DOI:10.3390/jcm11143960. PMID:35887723. IF:3.900(Q2/4D).
01/07/2022
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe
Amele, S, Sandri, AK, Rodger, A, Vandekerckhove, L, Benfield, T, Milinkovic, A, Duvivier, C, Stellbrink, HJ, Sambatakou, H, Chkhartishvili, N, Caldeira, L, Laguno, M, Domingo, P, Wandeler, G, Gisinger, M, Kuzovatova, E, Dragovic, G, Knysz, B, Matulionyte, R, Rockstroh, JK, Lundgren, JD, Mocroft, A, Peters, L. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13212. PMID:34882940. IF:3.000(Q3/7D).
01/07/2022
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study
Mocroft, A, Miro, JM, Wandeler, G, Llibre, JM, Boyd, A, van Bremen, K, Beniowski, M, Mikhalik, J, Cavassini, M, Maltez, F, Duvivier, C, Foppa, CU, Knysz, B, Bakowska, E, Kuzovatova, E, Domingo, P, Zagalo, A, Viard, JP, Degen, O, Milinkovic, A, Benfield, T, Peters, L. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13210. PMID:34889022. IF:3.000(Q3/7D).
01/07/2022
Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT
Franquet, T, Gimenez, A, Ketai, L, Mazzini, S, Rial, A, Pomar, V, Domingo, P. Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT. EUROPEAN RADIOLOGY. 2022; 32(7)DOI:10.1007/s00330-022-08580-2. PMID:35226158. IF:5.900(Q1/2D).
01/07/2022
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021) (vol 24, pg 646, 2022)
Capdevila, J, Gomez, MA, Guillot, M, Paez, D, Pericay, C, Safont, MJ, Tarazona, N, Vera, R, Vidal, J, Sastre, J. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021) (vol 24, pg 646, 2022). Clinical & Translational Oncology. 2022; 24(7)DOI:10.1007/s12094-022-02855-2. PMID:35596046. IF:3.400(Q3/6D).
01/07/2022
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021) (vol 24, pg 712, 2022)
Majem, M, de las Penas, R, Virizuela, JA, Cabezon-Gutierrez, L, Cruz, P, Lopez-Castro, R, Mendez, M, Mondejar, R, Munoz, MD, Escobar, Y. SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021) (vol 24, pg 712, 2022). Clinical & Translational Oncology. 2022; 24(7)DOI:10.1007/s12094-022-02846-3. PMID:35567734. IF:3.400(Q3/6D).
01/07/2022
Cabozantinib for the treatment of solid tumors: a systematic review
Maroto, P, Porta, C, Capdevila, J, Apolo, AB, Viteri, S, Rodriguez-Antona, C, Martin, L, Castellano, D. Cabozantinib for the treatment of solid tumors: a systematic review. Therapeutic Advances in Medical Oncology. 2022; 14DOI:10.1177/17588359221107112. PMID:35847482. IF:4.900(Q2/4D).
01/07/2022
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
Castellano, D, Apolo, AB, Porta, C, Capdevila, J, Viteri, S, Rodriguez-Antona, C, Martin, L, Maroto, P. Cabozantinib combination therapy for the treatment of solid tumors: a systematic review. Therapeutic Advances in Medical Oncology. 2022; 14DOI:10.1177/17588359221108691. PMID:35923927. IF:4.900(Q2/4D).
01/07/2022
Involvement of the PI3K/AKT Intracellular Signaling Pathway in the AntiCancer Activity of Hydroxytyrosol, a Polyphenol from Olea europaea, in Hematological Cells and Implication of HSP60 Levels in Its Anti-Inflammatory Activity
Parra-Perez, AM, Perez-Jimenez, A, Gris-Cardenas, I, Bonel-Perez, GC, Carrasco-Diaz, LM, Mokhtari, K, Garcia-Salguero, L, Lupianez, JA, Rufino-Palomares, EE. Involvement of the PI3K/AKT Intracellular Signaling Pathway in the AntiCancer Activity of Hydroxytyrosol, a Polyphenol from Olea europaea, in Hematological Cells and Implication of HSP60 Levels in Its Anti-Inflammatory Activity. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(13)DOI:10.3390/ijms23137053. PMID:35806065. IF:5.600(Q1/3D).
01/07/2022
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
Alvarez-Larran, A, Garrote, M, Ferrer-Marin, F, Perez-Encinas, M, Mata-Vazquez, MI, Bellosillo, B, Arellano-Rodrigo, E, Gomez, M, Garcia, R, Garcia-Gutierrez, V, Gasior, M, Cuevas, B, Angona, A, Gomez-Casares, MT, Martinez, CM, Magro, E, Ayala, R, del Orbe-Barreto, R, Perez-Lopez, R, Fox, ML, Raya, JM, Guerrero, L, Garcia-Hernandez, C, Caballero, G, Murillo, I, Xicoy, B, Ramirez, MJ, Carreno-Tarragona, G, Hernandez-Boluda, JC, Pereira, A. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. CANCER. 2022; 128(13)DOI:10.1002/cncr.34195. PMID:35417564. IF:6.200(Q1/3D).
01/07/2022
Causes of long-term mortality in patients with head and neck squamous cell carcinomas
Lop, J, Venegas, MD, Pujol, A, Sauter, B, Vasquez, R, Casasayas, M, Quer, M, Leon, X. Causes of long-term mortality in patients with head and neck squamous cell carcinomas. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(7)DOI:10.1007/s00405-021-07211-8. PMID:34905065. IF:2.600(Q2/3D).
01/07/2022
Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy
Leon, X, Garcia, J, Pujol, A, de Juan, J, Vasquez, R, Quer, M, Camacho, M. Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(7)DOI:10.1007/s00405-021-07223-4. PMID:34993612. IF:2.600(Q2/3D).
01/07/2022
Percutaneous closure of left ventricular pseudoaneurysm. Case resolution
Alonso, LG, Aizpurua, DA, Alvarez, XM, Serra, LA, Sanabria, MT, Li, CH. Percutaneous closure of left ventricular pseudoaneurysm. Case resolution. REC, interventional cardiology. 2022; 4(3)DOI:10.24875/RECICE.M22000285. PMID:. IF:(Q/D).
01/07/2022
Percutaneous closure of left ventricular pseudoaneurysm
Alonso, LG, Aizpurua, DA, Alvarez, XM, Serra, LA, Sanabria, MT, Li, CH. Percutaneous closure of left ventricular pseudoaneurysm. REC, interventional cardiology. 2022; 4(3)DOI:10.24875/RECICE.M22000284. PMID:. IF:(Q/D).
01/07/2022
Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland
Quilis, N, Vela, P, Caceres, BAB, Diaz-Torne, C, Calvo-Aranda, E, Sivera, F, Prada-Ojeda, A, Ruiz, FP, Pascual, E, Andres, M. Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland. ANNALS OF THE RHEUMATIC DISEASES. 2022; 81(7)DOI:10.1136/annrheumdis-2020-218226. PMID:32616605. IF:27.400(Q1/1D).
01/07/2022
Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients
Mazuecos, A, Villanego, F, Zarraga, S, Lopez, V, Oppenheimer, F, Llinas-Mallol, L, Hernandez, AM, Rivas, A, Ruiz-Fuentes, MC, Toapanta, NG, Jimenez, C, Cabello, S, Beneyto, I, Aladren, MJ, Rodriguez-Benot, A, Canal, C, Molina, M, Perez-Flores, I, Saura, IM, Gavela, E, Franco, A, Lorenzo, I, Galeano, C, Tabernero, G, Perez-Tamajon, L, Martin-Moreno, PL, Fernandez-Giron, F, Siverio, O, Labrador, PJ, De Arriba, G, Simal, F, Cruzado, L, Moina, I, Alcalde, G, Sanchez-Alvarez, E, Pascual, J, Crespo, M. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients. TRANSPLANTATION. 2022; 106(7)DOI:10.1097/TP.0000000000004119. PMID:35384924. IF:6.200(Q1/1D).
01/07/2022
Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020
Ars, E, Bernis, C, Fraga, G, Furlano, M, Martinez, V, Martins, J, Ortiz, A, Perez-Gomez, MV, Rodriguez-Perez, JC, Sans, L, Torra, R. Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020. NEFROLOGIA. 2022; 42(4)DOI:10.1016/j.nefro.2021.05.009. PMID:36404270. IF:2.600(Q3/6D).
01/07/2022
Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study
Puertolas-Gracia, B, Barbaglia, MG, Gotsens, M, Pares-Badell, O, Brugal, MT, Torrens, M, Trevino, L, Rodriguez-Diaz, C, Vazquez-Vazquez, JM, Pascual, A, Coromina-Gimferrer, M, Jimenez-Duenas, M, Oliva, I, Gonzalez, E, Mestre, N, Bartroli, M. Lifetime Dual Disorder Screening and Treatment Retention: A Pilot Cohort Study. Journal of Clinical Medicine. 2022; 11(13)DOI:10.3390/jcm11133760. PMID:35807045. IF:3.900(Q2/4D).
01/07/2022
Impact of R-Carvedilol on beta 2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes
Casabella-Ramon, S, Jimenez-Sabado, V, Tarifa, C, Casellas, S, Lu, TT, Izquierdo-Castro, P, Gich, I, Jimenez, M, Ginel, A, Guerra, JM, Chen, SRW, Benitez, R, Hove-Madsen, L. Impact of R-Carvedilol on beta 2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes. Biomedicines. 2022; 10(7)DOI:10.3390/biomedicines10071759. PMID:35885069. IF:4.700(Q1/3D).
01/07/2022
Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: When and which patients can benefit most from it?
Sanguedolce, F, Meneghetti, I, Bevilacqua, G, Montano, B, Martinez, C, Territo, A, Balana, J, Palou, J, Breda, A. Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: When and which patients can benefit most from it?. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2022; 40(7)DOI:10.1016/j.urolonc.2022.02.013. PMID:35400568. IF:2.700(Q2/5D).
30/06/2022
CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
Canada-Garcia, JE, Moure, Z, Sola-Campoy, PJ, Delgado-Valverde, M, Cano, ME, Gijon, D, Gonzalez, M, Gracia-Ahufinger, I, Larrosa, N, Mulet, X, Pitart, C, Rivera, A, Bou, G, Calvo, J, Canton, R, Gonzalez-Lopez, JJ, Martinez-Martinez, L, Navarro, F, Oliver, A, Palacios-Baena, ZR, Pascual, A, Ruiz-Carrascoso, G, Vila, J, Aracil, B, Perez-Vazquez, M, Oteo-Iglesias, J. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3. Frontiers in Microbiology. 2022; 13DOI:10.3389/fmicb.2022.918362. PMID:35847090. IF:5.200(Q2/3D).
29/06/2022
Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study
Saumoy, M, Sanchez-Quesada, JL, Assoumou, L, Gatell, JM, Gonzalez-Cordon, A, Guaraldi, G, Domingo, P, Giacomelli, A, Connault, J, Katlama, C, Masia, M, Ordonez-Llanos, J, Pozniak, A, Martinez, E, Podzamczer, D. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(7)DOI:10.1093/jac/dkac117. PMID:35411401. IF:5.200(Q1/3D).
28/06/2022
Metformin for treatment of cytopenias in children and young adults with Fanconi anemia
Pollard, JA, Furutani, E, Liu, SS, Esrick, E, Cohen, LE, Bledsoe, J, Liu, CW, Lu, K, de Haro, MJR, Sumalles, J, Malsch, M, Kuniholm, A, Galvin, A, Armant, M, Kim, AS, Ballotti, K, Moreau, L, Zhou, Y, Babushok, D, Boulad, F, Carroll, C, Hartung, H, Hont, A, Nakano, T, Olson, T, Sze, SG, Thompson, AA, Wlodarski, MW, Gu, XS, Libermann, TA, D'Andrea, A, Grompe, M, Weller, E, Shimamura, A. Metformin for treatment of cytopenias in children and young adults with Fanconi anemia. Blood Advances. 2022; 6(12)DOI:10.1182/bloodadvances.2021006490. PMID:35500223. IF:7.500(Q1/2D).